_highlights-and-key-clinical-trial-updates-from-asco-gi-2022-preview-1.jpg "Highlights and key clinical trial updates from ASCO GI 2022 from regorafenib nivolumab asco Video Screenshot Preview 1")
Gallery_highlights-and-key-clinical-trial-updates-from-asco-gi-2022-preview-3.jpg "Highlights and key clinical trial updates from ASCO GI 2022 from regorafenib nivolumab asco Video Screenshot Preview 3")
Gallery_highlights-and-key-clinical-trial-updates-from-asco-gi-2022-preview-hqdefault.jpg "Highlights and key clinical trial updates from ASCO GI 2022 from regorafenib nivolumab asco Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 31 seconds
👁 View: 280 times
Play Audio:👁 View: 280 times
Description:
VJOncology
VJOncology
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_renobate-investigating-regorafenib-plus-nivolumab-as-1st-line-therapy-for-unresectable-hcc.webp "VJOncology")
⏲ 2 minutes 53 seconds 👁 53
_regina-regorafenib-nivolumab-and-short-course-radiotherapy-for-rectal-cancer.webp "VJOncology")
⏲ 1 minute 53 seconds 👁 84
_dr-fukuoka-on-dosage-for-regorafenib-nivolumab-combo-in-gastric-cancer-and-crc.webp "OncLiveTV")
⏲ 1 minute 20 seconds 👁 157
_gi-asco-2020-recap-webinar.webp "Fight Colorectal Cancer")
_combination-therapy-updates-from-asco-2019.webp "OncLiveTV")
_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc.webp "VJOncology")
_therapeutic-approach-for-hcc-progression.webp "Targeted Oncology")
_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc.webp "VJOncology")
⏲ 2 minutes 52 seconds 👁 46
Related Video Searches
Back to Search
Search Videos
Recent Searches
×
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
_renobate-investigating-regorafenib-plus-nivolumab-as-1st-line-therapy-for-unresectable-hcc.jpg)
_regina-regorafenib-nivolumab-and-short-course-radiotherapy-for-rectal-cancer.jpg)
_dr-fukuoka-on-dosage-for-regorafenib-nivolumab-combo-in-gastric-cancer-and-crc.jpg)
_gi-asco-2020-recap-webinar.jpg)
_combination-therapy-updates-from-asco-2019.jpg)
_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc.jpg)
_therapeutic-approach-for-hcc-progression.jpg)
_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc.jpg)
❮❯
1 / 12
2 / 12
3 / 12
4 / 12
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
5 / 12
6 / 12
7 / 12
8 / 12
9 / 12
10 / 12
11 / 12
12 / 12
![[+]](/images/menu.gif){kind=small}